top of page

The Role of Placebos in Clinical Trials

Clinical trials are intricate processes designed to rigorously evaluate the safety and efficacy of new treatments. Within this framework, the use of placebos is a common and essential component. In this blog, we'll explore the role of placebos in clinical trials, demystifying their purpose and ethical considerations.

Understanding Placebos

What is a Placebo?

A placebo is an inactive substance, often a sugar pill or saline solution, that has no therapeutic effect. In clinical trials, placebos are used as a benchmark to assess the real effects of a new treatment. Participants are often unaware of whether they are receiving the experimental treatment or a placebo, a practice known as blinding (1).

The Placebo Effect

Interestingly, the placebo effect refers to the psychological and physiological changes that occur in participants even when they receive an inactive substance. This effect underscores the power of the mind in influencing health outcomes and is a crucial aspect of understanding treatment responses in clinical trials (2).

The Purpose of Placebos

Establishing Treatment Efficacy

The primary purpose of using placebos is to establish the true efficacy of a new treatment. By comparing the outcomes of participants receiving the experimental treatment with those receiving a placebo, researchers can confidently attribute any observed effects to the active treatment rather than external factors (3).

Eliminating Bias

Blinding, where participants and often researchers are unaware of who is receiving the active treatment, helps eliminate bias in reporting and evaluation. This ensures that the results of the trial are objective and free from preconceived notions (4).

Ethical Considerations

Ensuring Participant Safety

While placebos play a vital role in research, it's crucial to highlight that the use of placebos is always carefully considered, especially when there are effective existing treatments for a condition. Participant safety is paramount, and researchers are ethically obligated to prioritize their well-being (5).

Informed Consent

Participants are informed about the possibility of receiving a placebo during the informed consent process. This transparency is essential to uphold ethical standards and ensure that participants are fully aware of the potential scenarios (6).

Placebos in Clinical Practice

Beyond Trials: The Placebo Effect

Interestingly, the placebo effect has implications beyond clinical trials. Even in clinical practice, when patients believe they are receiving a treatment, their psychological response can lead to measurable improvements. This phenomenon underscores the complex interplay between the mind and the body in health outcomes (7).

Advancements in Research

As clinical research evolves, researchers are exploring ways to leverage the placebo effect to enhance treatment outcomes. Understanding the psychological and neurobiological mechanisms behind the placebo response may open doors to novel therapeutic approaches (8).


Placebos, often viewed as inert substances, play a pivotal role in the scientific rigor of clinical trials. They serve as a benchmark for evaluating treatment efficacy, help eliminate bias, and contribute to the robustness of research findings. Ethical considerations, including informed consent and participant safety, guide their careful use in the pursuit of advancing medical knowledge.

For more information regarding our currently enrolling trials and volunteer opportunities, please visit our website at WWW.HRIAZ.COM or call us at 602-288-HOPE



  1. NIH - What Is a Placebo?

  2. Harvard Health Blog - The Power of the Placebo Effect

  3. FDA - The Use of Placebo in Drug Development

  4. JAMA - Blinding in Randomized Controlled Trials: Evidence of Bias

  5. World Health Organization - Use of Placebos in Vaccine Trials

  6. Cleveland Clinic - Placebo Effect in Medicine: What Is It and How Does It Work?

  7. Science Translational Medicine - Harnessing the Placebo Effect: Exploring the Influence of Physician Characteristics on Placebo Response

  8. The Lancet - Open-label placebo treatment in chronic low back pain: a randomized controlled trial



bottom of page